Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK) Insider Trading
Directors, officers and holders of more than 10% of WHWK report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 74 transactions on file: 0 with code P, 12 with code S and 38 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Dornan David | Chief Scientific Officer | A Award | 85,887 | Not measured | Not measured |
| Sep 15, 2026 | BALL BRYAN | See remarks | A Award | 91,633 | Not measured | Not measured |
| Sep 15, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | A Award | 193,957 | Not measured | Not measured |
| Sep 15, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | A Award | 193,957 | Not measured | Not measured |
| Sep 15, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award | 118,476 | Not measured | Not measured |
| Sep 15, 2026 | Dugan Margaret | Chief Medical Officer | A Award | 81,250 | Not measured | Not measured |
| Sep 15, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award | 118,476 | Not measured | Not measured |
| Sep 15, 2026 | Dugan Margaret | Chief Medical Officer | A Award | 81,250 | Not measured | Not measured |
| Sep 15, 2026 | BALL BRYAN | See remarks | A Award | 91,633 | Not measured | Not measured |
| Sep 15, 2026 | Dornan David | Chief Scientific Officer | A Award | 85,887 | Not measured | Not measured |
| Sep 9, 2026 | Iyengar Vijay K | Director | A Award | 76,080 | Not measured | Not measured |
| Jun 12, 2026 | Zhao Baiteng | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Maroun Richard E | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Desai Neil | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Castelein Caley | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Aghazadeh Behzad | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Hirmand Mohammad | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Dalal Anupam | Director | A Award | 38,040 | Not measured | Not measured |
| Jun 12, 2026 | Reeve Emma | Director | A Award | 38,040 | Not measured | Not measured |
| May 14, 2026 | Castelein Caley | Director | A Award | 2,072,756 | $8124996.24 | $16,841,134,706,437 |
| May 14, 2026 | Dalal Anupam | Director | A Award | 1,275,510 | $3.92 | $4,999,999 |
| May 14, 2026 | Castelein Caley | Director | A Award | 255,102 | $3.92 | $1,000,000 |
| May 14, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | A Award | 51,021 | $3.92 | $200,002 |
| May 14, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award | 38,265 | $3.92 | $149,999 |
| May 14, 2026 | BALL BRYAN | See remarks | A Award | 51,020 | $3.92 | $199,998 |
| May 14, 2026 | Dugan Margaret | Chief Medical Officer | A Award | 19,132 | $3.92 | $74,997 |
| May 12, 2026 | Avoro Capital Advisors LLC | Director | A Award | 6,377,714 | $3.92 | $25,000,001 |
| Apr 16, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S Sale | 141,600 | $4.13 | $584,808 |
| Apr 15, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S Sale | 77,000 | $3.86 | $297,220 |
| Apr 14, 2026 | BALL BRYAN | See remarks | S Sale | 92,460 | $3.64 | $336,554 |
| Apr 13, 2026 | BALL BRYAN | See remarks | S Sale | 26,389 | $3.46 | $91,306 |
| Apr 10, 2026 | BALL BRYAN | See remarks | S Sale | 6,596 | $3.43 | $22,624 |
| Apr 9, 2026 | BALL BRYAN | See remarks | S Sale | 50,000 | $3.57 | $178,500 |
| Apr 9, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 14,500 | $3.38 | $49,010 |
| Apr 8, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 63,945 | $3.40 | $217,413 |
| Apr 7, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 94,087 | $3.43 | $322,718 |
| Apr 6, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 102,395 | $3.51 | $359,406 |
| Apr 2, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 26,858 | $3.48 | $93,466 |
| Apr 1, 2026 | BALL BRYAN | See remarks | M Exercise | 366,532 | Not measured | Not measured |
| Apr 1, 2026 | BALL BRYAN | See remarks | A Award | 250,058 | Not measured | Not measured |
| Apr 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | M Exercise | 775,828 | Not measured | Not measured |
| Apr 1, 2026 | Dornan David | Chief Scientific Officer | A Award | 282,340 | Not measured | Not measured |
| Apr 1, 2026 | Dugan Margaret | Chief Medical Officer | A Award | 283,157 | Not measured | Not measured |
| Apr 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | A Award | 831,148 | Not measured | Not measured |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M Exercise | 473,902 | Not measured | Not measured |
| Apr 1, 2026 | BALL BRYAN | See remarks | M Exercise | 366,532 | Not measured | Not measured |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M Exercise | 473,902 | Not measured | Not measured |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award | 300,677 | Not measured | Not measured |
| Apr 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER | M Exercise | 775,828 | Not measured | Not measured |
| Mar 2, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S Sale | 2,594 | $3.31 | $8,585 |
The full Form 4 history is on the WHWK company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.